|
|
North Carolina Translational and Clinical Science Institute (NC TraCS) KL2 |
| 5KL2TR002490-05 |
|
NCATS |
2022 |
|
|
Institutional Career Development Core |
| 5KL2TR002530-05 |
|
NCATS |
2022 |
|
|
Institutional Career Development Core |
| 5KL2TR002534-05 |
|
NCATS |
2022 |
|
|
A consortium effort to translate therapies for neurological diseases via an ex vivo organotypic platform |
| 5U01TR003715-02 |
|
NCATS |
2022 |
|
|
Understanding role of circadian disruption in pathogenesis of MS |
| 1R01NS123532-01A1 |
|
NINDS |
2022 |
|
|
Seronegative Autoimmune Encephalopathies: Biomarker Discovery, Validation & Deep Phenotyping |
| 1R01NS126227-01 |
|
NINDS |
2022 |
|
|
Exploring Akkermansia Genomic and Functional Diversity in Neurologic Diseases |
| 1R21NS126866-01 |
|
NINDS |
2022 |
|
|
Investigating how the microbiota modulates neuroinflammatory signaling and neurodegeneration in Parkinsons disease and dementia |
| 1R21NS130500-01 |
|
NINDS |
2022 |
|
|
KPTN Loss and Megalencephaly: mTOR Activation as Therapeutic Target |
| 1R37NS125632-01 |
|
NINDS |
2022 |
|
|
α-Synuclein strain properties are associated with diagnosis of and progression to Parkinsons disease with dementia |
| 1RF1NS125592-01 |
|
NINDS |
2022 |